High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence.

导出 LinkOut

翻译打印收藏纠错

作者： Sandrine,Nugteren ^[1] ; Sjoerd H,den Uil ^[2] ; Pien M,Delis-van Diemen ^[3] ; Ytje,Simons-Oosterhuis ^[1] ; Dicky J,Lindenbergh-Kortleve ^[1] ; Daniëlle H,van Haaften ^[1] ; Hein B A C,Stockmann ^[2] ; Joyce,Sanders ^[3] ; Gerrit A,Meijer ^[3] ; Remond J A,Fijneman ^[3] ; Janneke N,Samsom ^[4]

作者单位： Division Gastroenterology and Nutrition, Laboratory of Pediatrics, Erasmus University Medical Center, Sophia Children's Hospital, Room Ee1567A, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. ^[1] Department of Surgery, Spaarne Gasthuis, Haarlem, The Netherlands. ^[2] Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. ^[3] Division Gastroenterology and Nutrition, Laboratory of Pediatrics, Erasmus University Medical Center, Sophia Children's Hospital, Room Ee1567A, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. j.samsom@erasmusmc.nl. ^[4]

主题词结直肠肿瘤(Colorectal Neoplasms);基因表达调控(Gene Expression Regulation);人类(Humans);肿瘤复发, 局部(Neoplasm Recurrence, Local);预后(Prognosis);分泌型白细胞蛋白酶抑制因子(Secretory Leukocyte Peptidase Inhibitor)

DOI 10.1038/s41598-022-16427-5

PMID 35842496

发布时间 2022-09-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交